Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Medscape Education Clinical Briefs October 24, 2012
In this case-control study of patients with glioblastoma multiforme, median overall survival time for those with multifocal tumors was shorter vs those with solitary tumors.
The FDA has approved immune globulin [human, 10%] intravenous infusion, iobenguane I 123 intravenous injection, and a new pen cartridge strength for somatropin [rDNA origin] injection.